Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years
Clinical trial NCT00372255 · COMPLETED
Trial details
- NCT number
- NCT00372255
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-17
- Primary completion
- 2006-03-28
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.